Vericel Corp. Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Global Market for Cell and Gene Therapy (BIO225B)

MACI		MACI received approval from the FDA for the treatment of symptomatic articular cartilage defects of the knee with or without bone involvement in adults.
Epicel		The FDA approved a Pediatric Labeling supplement for Epicel, which specified use in both adult and pediatric patients, added pediatric labeling information, and granted an exemption from the profit prohibition.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.